Dimensional Fund Advisors
VYGR icon

Dimensional Fund Advisors’s Voyager Therapeutics VYGR Stock Holding History

Dimensional Fund Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Sell
875,568
-208,931
-19% -$823K ﹤0.01% 2601
2025
Q4 		$4.26M Sell
1,084,499
-198,657
-15% -$879K ﹤0.01% 2575
2025
Q3 		$5.99M Sell
1,283,156
-138,026
-10% -$499K ﹤0.01% 2487
2025
Q2 		$4.42M Sell
1,421,182
-75,102
-5% -$242K ﹤0.01% 2563
2025
Q1 		$5.06M Buy
1,496,284
+115,669
+8% +$540K ﹤0.01% 2492
2024
Q4 		$7.83M Buy
1,380,615
+275,571
+25% +$1.78M ﹤0.01% 2401
2024
Q3 		$6.46M Buy
1,105,044
+291,364
+36% +$2.12M ﹤0.01% 2442
2024
Q2 		$6.44M Sell
813,680
-291,875
-26% -$2.45M ﹤0.01% 2400
2024
Q1 		$10.3M Buy
1,105,555
+173,324
+19% +$1.46M ﹤0.01% 2304
2023
Q4 		$7.87M Buy
932,231
+153,291
+20% +$1.11M ﹤0.01% 2414
2023
Q3 		$6.04M Buy
778,940
+445,545
+134% +$4.07M ﹤0.01% 2470
2023
Q2 		$3.82M Buy
333,395
+103,548
+45% +$1.07M ﹤0.01% 2606
2023
Q1 		$1.77M Buy
229,847
+89,036
+63% +$708K ﹤0.01% 2769
2022
Q4 		$859 Buy
140,811
+46,788
+50% +$266K ﹤0.01% 2931
2022
Q3 		$556K Sell
94,023
-16,403
-15% -$105K ﹤0.01% 3022
2022
Q2 		$652K Buy
110,426
+79,166
+253% +$535K ﹤0.01% 3010
2022
Q1 		$238K Hold
31,260
– – ﹤0.01% 3286
2021
Q4 		$85K Sell
31,260
-14,765
-32% -$50.4K ﹤0.01% 3453
2021
Q3 		$121K Sell
46,025
-6,295
-12% -$20.4K ﹤0.01% 3407
2021
Q2 		$216K Sell
52,320
-8,541
-14% -$38.7K ﹤0.01% 3326
2021
Q1 		$287K Buy
60,861
+12,949
+27% +$88.3K ﹤0.01% 3235
2020
Q4 		$343K Buy
47,912
+1,741
+4% +$16.7K ﹤0.01% 3157
2020
Q3 		$493K Hold
46,171
– – ﹤0.01% 3064
2020
Q2 		$583K Buy
46,171
+2,520
+6% +$29.3K ﹤0.01% 3044
2020
Q1 		$399K Buy
43,651
+30,378
+229% +$349K ﹤0.01% 3096
2019
Q4 		$185K Buy
+13,273
New +$193K ﹤0.01% 3267
2019
Q1 		– Sell
-13,786
Closed -$130K – 3462
2018
Q4 		$130K Sell
13,786
-5,623
-29% -$72.2K ﹤0.01% 3334
2018
Q3 		$367K Sell
19,409
-20,484
-51% -$393K ﹤0.01% 3222
2018
Q2 		$780K Sell
39,893
-41,553
-51% -$821K ﹤0.01% 3063
2018
Q1 		$1.53M Sell
81,446
-23,526
-22% -$508K ﹤0.01% 2916
2017
Q4 		$1.74M Sell
104,972
-942
-0.9% -$16.1K ﹤0.01% 2879
2017
Q3 		$2.18M Buy
105,914
+7,786
+8% +$87.9K ﹤0.01% 2840
2017
Q2 		$879K Buy
98,128
+68,574
+232% +$690K ﹤0.01% 3000
2017
Q1 		$391K Buy
+29,554
New +$359K ﹤0.01% 3128

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors's VYGR Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Voyager Therapeutics (VYGR) stake by 19% in Q1 2026, selling an estimated $823K and leaving 875,568 shares worth $3.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

Dimensional Fund Advisors first reported a position in VYGR in Q1 2017 and has held it in 34 quarters since. The position peaked at $10.3M in Q1 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Dimensional Fund Advisors held 875,568 shares of Voyager Therapeutics worth $3.38M as of Q1 2026.
  • Dimensional Fund Advisors sold 208,931 Voyager Therapeutics shares in Q1 2026, an estimated $823K.
  • Voyager Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2601 holding.
  • Dimensional Fund Advisors first reported a position in Voyager Therapeutics in Q1 2017 and has held it in 34 quarters since.
  • Dimensional Fund Advisors's Voyager Therapeutics position peaked at $10.3M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.